The moving averages on the daily timeframe suggest a bullishness in price, as the 20, 50, 100 and 200 are all in a bullish alignment -- meaning the shorter durations are above the...
By Yasin EbrahimInvesting.com – The S&P 500 closed at record highs Thursday, shrugging off the hottest pace of inflation in decades as Treasury yields slipped on signs bond bears...
By Yasin EbrahimInvesting.com – The S&P 500 remained near all-time highs Thursday, after a hot inflation report failed to coax the bond bears out of hiding as yields fell,...
The pandemic-hit investment world, during the process of finding COVID-proof profitable sectors, has by now recognized MedTech’s unabated and nuanced growth trend. During the...
For Immediate ReleaseChicago, IL – March 26, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts...
As the world eagerly awaits results for the U.S. Presidential election, there's yet another highly anticipated event: a breakthrough in the coronavirus vaccine.Positive news about...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Neutral | Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Buy | Strong Buy | Strong Buy |
| Summary | Sell | Sell | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,724.60 | 2,765.00 | 2,706.70 | +86.6 | +3.28% | 3.57M | NASDAQ | |||
| 373.58 | 377.54 | 367.00 | +5.77 | +1.57% | 15.95M | NASDAQ | |||
| 194.86 | 196.40 | 189.76 | +8.79 | +4.72% | 27.27M | NYSE | |||
| 53.12 | 53.92 | 52.94 | -0.06 | -0.11% | 18.59M | NASDAQ | |||
| 120.71 | 121.07 | 119.33 | +0.90 | +0.75% | 1.86M | NYSE | |||
| 195.37 | 196.46 | 189.95 | +3.29 | +1.71% | 14.87M | NASDAQ | |||
| 43.47 | 43.74 | 42.26 | +1.37 | +3.25% | 37.58M | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 21.15 | 21.25 | 20.91 | +0.16 | +0.76% | 7.30M | NYSE | |||
| 142.27 | 142.46 | 140.15 | +1.34 | +0.95% | 4.16M | NASDAQ | |||
| 53.84 | 53.92 | 53.02 | +0.24 | +0.45% | 96.42K | NYSE | |||
| 41.22 | 41.87 | 39.80 | +1.86 | +4.73% | 50.67M | NYSE | |||
| 198.52 | 200.19 | 198.10 | -1.95 | -0.97% | 1.02M | NYSE | |||
| 6.195 | 6.245 | 6.11 | +0.045 | +0.73% | 8.14M | NYSE | |||
| 27.92 | 28.29 | 27.86 | -0.28 | -0.99% | 19.82M | NYSE |
Bio-Rad Laboratories, Inc. develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
